Performance of the T2Candida Panel for the Diagnosis of Intra-abdominal Candidiasis
Author(s) -
Frédéric Lamoth,
Cornelius J. Clancy,
Frédéric Tissot,
Kevin M Squires,
Philippe Eggimann,
Ursula Flückiger,
Martin Siegemund,
Christina Orasch,
Stefan Zimmerli,
Thierry Calandra,
Oscar Marchetti,
Minh Nguyen,
PierreYves Bochud
Publication year - 2020
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofaa075
Subject(s) - medicine , invasive candidiasis , predictive value , positive predicative value , gastroenterology , dermatology , fluconazole , antifungal
Performance of T2Candida for detecting intra-abdominal candidiasis (IAC) was assessed in 48 high-risk patients. T2Candida sensitivity/specificity and positive/negative predictive values were 33%/93% and 71%/74%, respectively. IAC was present in 100% of cases with concordant positive T2Candida/1,3-beta-d-glucan and absent in 90% of concordant negative results. Combination T2Candida/1,3-beta-d-glucan may help guide treatment decisions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom